Publications

Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report.

Merle, CS; RTSS-SMC working group,;

2023

Malaria journal, (2023).22 1 10.1186/s12936-023-04657-5.

Plasmodium falciparum gametocyte carriage in longitudinally monitored incident infections is associated with duration of infection and human host factors.

Andolina, C; Ramjith, J; Rek, J; Lanke, K; Okoth, J; GRIGNARD, L; Arinaitwe, E; Briggs, J; Bailey, J; Aydemir, O; Kamya, MR; Greenhouse, B; Dorsey, G; Staedke, SG; DRAKELEY, C; Jonker, M; Bousema, T;

2023

Scientific reports, (2023).13 1 10.1038/s41598-023-33657-3.

Artemisinin-Resistant and HRP-Negative Malaria Parasites in Africa.

GREENWOOD, B;

2023

The New England journal of medicine, (2023).389 13 10.1056/nejmp2309142.

Human monoclonal antibodies inhibit invasion of transgenic Plasmodium knowlesi expressing Plasmodium vivax Duffy binding protein.

Watson, QD; Carias, LL; Malachin, A; Redinger, KR; Bosch, J; Bardelli, M; Baldor, L; Feufack-Donfack, LB; Popovici, J; MOON, RW; Draper, SJ; Zimmerman, PA; King, CL;

2023

Malaria journal, (2023).22 1 10.1186/s12936-023-04766-1.

Assessing the variability in experimental hut trials evaluating insecticide-treated nets against malaria vectors.

Challenger, JD; Nash, RK; NGUFOR, C; Sanou, A; Toé, KH; Moore, S; Tungu, PK; ROWLAND, M; Foster, GM; N'GUESSAN, R; Sherrard-Smith, E; Churcher, TS;

2023

Current research in parasitology & vector-borne diseases, (2023).3, 10.1016/j.crpvbd.2023.100115.

Seasonal vaccination with RTS,S/AS01E vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trial.

Dicko, A; Ouedraogo, J-B; Zongo, I; Sagara, I; CAIRNS, M; Yerbanga, RS; Issiaka, D; Zoungrana, C; Sidibe, Y; Tapily, A; Nikièma, F; Sompougdou, F; Sanogo, K; Kaya, M; Yalcouye, H; Dicko, OM; Diarra, M; Diarra, K; Thera, I; Haro, A; Sienou, AA; Traore, S; Mahamar, A; Dolo, A; Kuepfer, I; ... GREENWOOD, B.

2023

The Lancet Infectious diseases, (2023).24 1 10.1016/S1473-3099(23)00368-7.

Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and Lumefantrine.

VAN SCHALKWYK, DA; PRATT, S; Nolder, D; Stewart, LB; Liddy, H; MUWANGUZI-KARUGABA, J; BESHIR, KB; Britten, D; Victory, E; Rogers, C; Millard, J; Brown, M; Nabarro, LE; Taylor, A; Young, BC; Chiodini, PL; SUTHERLAND, CJ;

2023

Clinical Infectious Diseases, (2023).78 2 10.1093/cid/ciad724.

Additional file 3 of Assessing the impact of the 'malaria supporters project' intervention to malaria control in the Brazilian Amazon: an interrupted time-series analysis.

Garcia, KK S; Soremekun, S; BOTTOMLEY, C; Abrahão, AA; De Miranda, CB; DRAKELEY, C; Ramalho, WM; Siqueira, AM;

2023

, Figshare (2023).

Master statistical analysis plan: attractive targeted sugar bait phase III trials in Kenya, Mali, and Zambia.

Yukich, J; Eisele, TP; TerKuile, F; Ashton, R; Staedke, S; Harris, AF; Johnson, PC D; SARRASSAT, S; Lesosky, M; BRADLEY, J; KLEINSCHMIDT, I; Littrell, M; Attractive Targeted Sugar Bait Phase III Trial Gro,;

2023

Trials, (2023).24 1 10.1186/s13063-023-07762-7.

A novel class of sulphonamides potently block malaria transmission by targeting a Plasmodium vacuole membrane protein.

Yahiya, S; Saunders, CN; Hassan, S; Straschil, U; Fischer, OJ; Rueda-Zubiaurre, A; Haase, S; Vizcay-Barrena, G; FAMODIMU, MT; Jordan, S; DELVES, MJ; Tate, EW; Barnard, A; Fuchter, MJ; Baum, J;

2023

Disease models & mechanisms, (2023).16 2 10.1242/dmm.049950.